TNF Pharmaceuticals announces 1-for-100 reverse stock split

TNF Pharmaceuticals (TNFA) announced that its board of directors has authorized a reverse stock split of the company’s common stock at a ratio of one post-split share for every 100 pre-split shares. The company’s common stock will begin trading on a split-adjusted basis upon market open on Tuesday, September 2. The company expects to provide operational business updates coinciding with the completion of the reverse stock split.